Business & regional news

New VitalFlow system expands Medtronic Cardiac Surgery’s portfolio globally

Medtronic expands its cardiac surgery portfolio with the European launch of the Penditure LAA Exclusion System

Dr. Arthur brings more than 20 years of experience as a practicing neurosurgeon and a commitment to innovation, patient safety, and improving stroke care outcomes

London office expansion underlines Medtronic’s commitment to fostering cross-industry collaboration, contributing to ambitions of the NHS 10-Year Health Plan and driving surgical innovation.

The pivotal Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial demonstrates global clinical effectiveness, long-term safety, and patient preference

After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.

Japan is now the 77th country to receive regulatory approval for the Symplicity Spyral Renal Denervation System

The upcoming U.S. launch of the small-diameter OmniaSecure defibrillation lead will introduce the first FDA-approved lead for both adults and adolescent pediatric patients

Indication demonstrates Medtronic’s commitment to innovative patient-centered solutions shaping the future of TAVR

To address the widespread prevalence of varicose veins as a serious health condition, Medtronic has launched the #KabTakKarogeIgnore campaign in India. The initiative aims to build awareness of...

Albany Medical Center performs first patient procedure in clinical trial for use of peripheral vasculature liquid embolization for active arterial hemorrhage

Data highlights Americans’ shifting preferences toward chronic condition management

Exclusive distribution agreement with FMD Co. Ltd. expands peripheral arterial disease treatment portfolio with new suite of guidewires

The company also announces plans to share new gynecologic data
for the Hugo™ RAS system and conduct a telesurgery demo at the
Society of Robotic Surgery 2025 Annual Meeting in Strasbourg, France

Medtronic advances pipeline with update on multi-organ denervation study and additional data recently presented at EuroPCR 2025

The renewed partnership builds on over 30 years of collaboration

Medtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of the VitalFlow ECMO System

IRCAD North America is a first-of-its-kind education and training destination in the U.S.

Customers are being asked to remove the affected devices from use and replace with an alternate means of ventilation

Large, international registry designed to expand real-world data for Symplicity blood pressure procedure for uncontrolled hypertension

Minimally invasive laser technology now with enhanced capital system improvements, offering new user interface, workflow efficiencies, and upgrade capabilities

Regulatory review process to give patients better access to innovation through expedited development, assessment, and review of investigational Nellcor™ technology

Medtronic, a global leader in healthcare technology, is proud to announce that it has been honored with the 2025 MedTech Breakthrough Award for 'Best Overall Medical Device Solution' for its...

Medtronic, a global leader in healthcare technology, announced today that it has received CE (Conformité Européenne) Mark approval for several expanded indications for the treatment of coronary...

The Medtronic TAVI indication builds upon commitment to provide best in class patient outcomes today and enabling lifetime management solutions for the future

Installed for the first time in Korea at Seoul National University Hospital… Treatment, research, and education using Hugo to be fully launched in Korea Hugo RAS system expected to be utilized...

Collaboration introduces the Dragonfly™* technology to U.S. market, designed to enhance stone clearance, enable larger biopsy samples, and improve precision in biliary and pancreatic duct procedures

Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease

With its advanced multi-beat hemodynamic algorithm, the Argos™ monitor expands the parameters in the Medtronic perioperative portfolio

New investigational energy waveforms created specifically to target ventricular arrhythmias

Ventricular arrhythmia research will provide important clinical evidence using a new technology for patient population in need of new treatment options

Medtronic Smart MDI system includes unique early notification feature for missed meal boluses and high glucose that enables users to bolus on time. Consistent response to these notifications was associated with Time in Range of 67% and 71%, respectively.

Company honored for its pulsed field ablation technologies to treat atrial fibrillation

Annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs

Data from the largest study comparing drug-coated balloons presented as a late-breaking clinical trial at Cardiovascular Research Technologies 2025